TrialHeadache2020

A Phase 1, Randomized, Open-Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects.

Detlef Albrecht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.